CHRISTOPHER S. HENNEY, PH.D., D.SC.
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Sarepta Therapeutics, Inc.
Filing Date
Source Excerpt
2010-05-04
Christopher S. Henney, Ph.D., D.Sc.(2)(4) 24,000 Fees Earned or Paid in Cash, 33,498 Option Awards, Total 57,498
Data sourced from SEC filings. Last updated: 2025-12-07